뒤로
Mydecine Innovations Group Inc(MYCOD) 가격
MYCOD 주가 차트
MYCOD 수입
Mydecine Innovations Group Inc
$0
0%
$0
오늘 기준:Feb 09, 16:48:22 GMT-5
Earnings FAQ
MYCOD의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Mydecine Innovations Group Inc MYCOD의 지난 분기 매출 실적은 어땠나요?
Mydecine Innovations Group Inc의 매출 추정치는 얼마인가요?
Mydecine Innovations Group Inc의 수익 품질 점수는 얼마인가요?
Mydecine Innovations Group Inc는 언제 수익을 보고하나요?
Mydecine Innovations Group Inc의 예상 수익은 얼마인가요?
Mydecine Innovations Group Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
283
EPS(TTM)
0.00
배당수익률
--
시가총액
--
MYDECINE INNOVATIONS GROUP INC 란 무엇인가요?
Mydecine Innovations Group Inc is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-08-18. Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The firm is engaged in developing the next generation of medications and therapies to address mental health disorders, such as nicotine addiction and post traumatic stress disorder (PTSD). The firm conducts research and development on novel second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The firm has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The firm is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). The company uses advanced artificial intelligence (AI) and machine learning to design and screen drugs of interest. Its subsidiaries include Mydecine Group (1220611 BC Ltd) and NeuroPharm Inc.